#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness bilateral Solitary fibrous tumour Pyruvate kinase deficiency anaemia Insulinoma KBG syndrome Niemann-Pick disease Cytokine release syndrome Colon cancer Acute graft versus host disease in liver Spinal muscular atrophy Vascular calcification Hepatocellular carcinoma Parkinson's disease IgA nephropathy Transient ischaemic attack More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Trials in Disease Cholangitis sclerosing – Treatment Marfan’s syndrome – Trials in Disease Propionic acidaemia – Life with Disease Haemolytic uraemic syndrome – Basic Information Amyotrophic lateral sclerosis Malignant fibrous histiocytoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS Retinitis pigmentosa – Diagnostics Indolent systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD6234 Recombinant Interferon Beta-1B Setanaxib Rct2100 Palopegteriparatide GSKVX000000048111 Disodium Folinate Jnj-64042056 GSK5460025A Panobinostat Bms-986442 Alirocumab 177Lu-Rhpsma-10.1 Alemtuzumab AMG 732 Pyridoxine Soya Oil Gad20-209-Fsp-A2 Bay 2927088 Bi 765845 More therapies…

    Learn about Your Condition

    Haematological infection Colon cancer stage III Myositis Renal cancer Dementia with Lewy bodies Graft versus host disease Hairy cell leukaemia Glomerulonephritis acute Hepatobiliary disease Implantation complication Vulvar dysplasia Angiosarcoma Supraventricular tachycardia Meningococcal infection Cerebellar ataxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Ifinatamab Deruxtecan
    Austria Czechia Denmark France Germany Greece +7

  • Study on Chemotherapy for Patients with Resected Pancreatic Cancer Using FOLFIRINOX and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Levoleucovorin
    • Fluorouracil
    • Gemcitabine
    France

  • Study on the Effectiveness of BP1.4979 for Adult Men with Premature Ejaculation

    Recruiting

    2 1
    Investigated Drugs:
    • N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
    France

  • Study on Reducing Morphine Use After Throat and Neck Cancer Surgery Using Ropivacaine and Sodium Chloride for Patients Undergoing Cancer Surgery

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine
    • Sodium Chloride
    France

  • Study of hydrocortisone and fludrocortisone in patients with intermediate/high-risk scheduled cardiac surgery to prevent complications

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute kidney injury
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Fludrocortisone
    • Hydrocortisone
    France

  • Study on Tislelizumab for Elderly Patients with Advanced Esophageal Squamous Cell Carcinoma Unfit for Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Tislelizumab
    France

  • Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Dimethyl Fumarate
    • Diroximel Fumarate
    • Interferon Beta-1A
    France

  • Study of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mrna-4157
    Denmark France Germany Greece Hungary Italy +3

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
Previous Page
1 … 4 5 6 7 8 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!